Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2019 | Identifying the factors in gene regulatory networking in AML

Constanze Bonifer • 8 Nov 2019
NCRI 2019
Acute Myeloid Leukemia Leukemia

Constanze Bonifer, PhD, University of Birmingham, Birmingham, UK, continues on the subject of sub-type specific aberrant transcriptional programming in acute myeloid leukemia (AML). Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.

More from Constanze Bonifer

3:48
The impact of various chromosomal abnormalities observed in AML & insights into RUNX1-ETO
Constanze Bonifer • 16 Mar 2023
3:15
The impact of CEBPA mutations & insights into the gene regulatory network of CEBPA-double mutant AML
Constanze Bonifer • 16 Mar 2023
4:09
Using transcriptional network analysis to better understand AML development and evolution
Constanze Bonifer • 16 Mar 2023
3:18
The molecular impact of RUNX1 mutations in AML
Constanze Bonifer • 16 Mar 2023

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
2:25
Optimizing haplo-SCT for the treatment of AML
Arnon Nagler • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals